Steroid effects on mucociliary clearance in outpatient asthma

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 19, Issue 2, 2006, Pages 208-220

  Shah, Rasik V ^a   Amin, Mohammad ^b   Sangwan, Sanjay ^b   Smaldone, Gerald C ^b  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Aerosol; Airway secretions; Deposition of particles; FEV1; Gamma camera

Indexed keywords

BUDESONIDE; CORTICOSTEROID; PLACEBO; PREDNISONE; SODIUM CHLORIDE; TECHNETIUM SULFUR COLLOID TC 99M; XENON 133;

ADULT; AEROSOL; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; ISOTOPE LABELING; MALE; MUCOCILIARY CLEARANCE; NEBULIZATION; OUTPATIENT; POST HOC ANALYSIS; SCINTILLATION CAMERA; SINGLE BLIND PROCEDURE;

ADMINISTRATION, INHALATION; ADULT; AGED; AMBULATORY CARE; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; PREDNISOLONE; SINGLE-BLIND METHOD;

EID: 33745612478     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2006.19.208     Document Type: Article

References (16)

1. Donna M.D., D. Bittesnich, A. Chetta, et al. 2000. The effect of inflammation on mucociliary clearance in asthma-an overview. Chest 118:1142-1149.
2. Messina, M.S., T.G. O'Riordan, and G.C. Smaldone. 1991. Changes in mucociliary clearance during acute exacerbations of asthma. Am. Rev. Respir. Dis. 143:993-997.
3. Bateman, J., D. Pavia, N.F. Sheahan, et al. 1983. Impaired tracheobronchial clearance in patients with mud stable asthma. Thorax 38:463-467.
4. O'Riordan, T.G., J. Zwang, and G.C. Smaldone. 1992. Mucociliary clearance in adult asthma. Am. Rev. Respir. Dis. 146:598-603.
5. Pavia, D., J.R.M. Bateman, N.F. Sheahan, et al. 1985. Tracheobronchial mucociliary clearance in asthma: impaired during remission. Thorax 38:463-467.
6. National Heart, Lung and Blood Institute, National Institute of Health. 1997. National Asthma Education Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report No. 2 (NIH publication no. 97-4051). National Institute of Health, Bethesda, MD.
7. Ellul-Micallef, R., S.A. Johansson. 1983. Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. Br. J. Clin. Pharm. 15:419-422.
8. Gibson, P.G., N. Saltos, K. Fakes. 2001. Acute anti-inflammatory effects of inhaled budesonide in asthma. Am. J. Respir. Crit. Care Med. 163:32-36.
9. American Thoracic Society Committee on Diagnostic Standards. 1987. Definitions and classification of chronic bronchitis, asthma and COPD. Am. Rev. Respir. Dis. 136:225-244.
10. Sangwan, S., B.K. Gurses, G.C. Smaldone. 2004. Face masks and facial deposition of aerosols. Pediatr. Pulmonol. 37:447-452.
11. Smaldone, G.C., R.J. Perry, W.D. Bennett, et al. 1988. Interpretation of "24 hours Lung Retention" in studies of mucociliary clearance. J. Aerosol Med. 1:11-20.
12. Agnew, J.E., J.R.M. Bateman, D. Pavia, et al. 1984. Peripheral airways mucus clearance in stable asthma is improved by oral corticosteroid therapy. Bull. Eur. Physiopathol. Respir. 20:295-301.
13. Clague, H., D. Ahmed, M.J. Chamberlain, et al. 1983. Histamine Bronchial Challenge: effect on regional ventilation and aerosol deposition. Thorax 38:668-675.
14. O'Riordan, T.G., L. Walser, and G.C. Smaldone. 1983. Changing patterns of aerosol deposition during methacholine bronchoprovocation. Chest 103:1385-1389.
15. Svartengren, M., M. Anderson, G. Bylin, et al. 1991. Regional deposition of 3.6 micron particles and lung function in asthmatic subjects. J. Appl. Physiol. 71(6):2238-2243.
16. Kharitonov, S.A., L.E. Donelley, P. Montuschi, et al. 2002. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 57:889-896.